Back to top

RESCISSION, RESTRUCTURING AND ASSIGNMENT AGREEMENT

Termination Agreement

RESCISSION, RESTRUCTURING AND ASSIGNMENT AGREEMENT | Document Parties: Holdings, Inc | INVESTMENT NETWORK, LLC You are currently viewing:
This Termination Agreement involves

Holdings, Inc | INVESTMENT NETWORK, LLC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: RESCISSION, RESTRUCTURING AND ASSIGNMENT AGREEMENT
Governing Law: California     Date: 2/2/2005
Law Firm: Rutan Tucker;Morrison Foerster    

RESCISSION, RESTRUCTURING AND ASSIGNMENT AGREEMENT, Parties: holdings  inc , investment network  llc
50 of the Top 250 law firms use our Products every day

 

                            RESCISSION, RESTRUCTURING

                            AND ASSIGNMENT AGREEMENT

 

      This Rescission, Restructuring and Assignment Agreement (this "AGREEMENT")

is entered   into as of January   27,   2005,   by and among   Integrated   Healthcare

Holdings,   Inc., a Nevada corporation (the "COMPANY"),   Kali P. Chaudhuri,   M.D.

("DR. CHAUDHURI"),   William E. Thomas ("THOMAS") (for purposes of Sections 3 and

10 only),   Anil V. Shah, M.D. ("DR.   SHAH") (for purposes of Sections 2(a) and 9

only), and Orange County Physicians   Investment   Network,   LLC, a Nevada limited

liability company ("OC-PIN").

 

                                 R E C I T A L S

 

      A. The Company and Dr. Chaudhuri are parties to a Secured Convertible Note

Purchase   Agreement dated as of September 28, 2004, which was amended by a First

Amendment to Secured   Convertible   Note Purchase   Agreement dated as of November

16,   2004   (collectively,   the   "PURCHASE   AGREEMENT"),   pursuant   to which   Dr.

Chaudhuri    was   issued   a   $500,000    Secured    Convertible    Promissory    Note

("CONVERTIBLE   NOTE"), a $10,000,000   Secured   Promissory Note ("SECURED NOTE"),

and a Stock Option Agreement dated November 16, 2004 ("STOCK OPTION AGREEMENT").

 

      B. The Company is in default of its   obligation   to repay the   Convertible

Note by December 31, 2004.

 

      C. The Company desires that OC-PIN invest in the Company.

 

      D. Dr. Chaudhuri and Dr. Shah, an authorized   representative and affiliate

of OC-PIN, are parties to a Non-Circumvention   Agreement dated November 11, 2004

("NON-CIRCUMVENTION AGREEMENT").

 

      E. As a condition to investment, OC-PIN has requested that the Convertible

Note, the Secured Note, the Stock Option Agreement and certain provisions of the

Agreement be rescinded and canceled, and Dr. Chaudhuri restructure his financial

arrangements   with the   Company,   and that he   terminate   the   Non-Circumvention

Agreement.   Dr.   Chaudhuri   is   willing   to reduce   his   contractual   rights and

participation and otherwise   accommodate the Company and OC-PIN on the terms and

subject to the conditions set forth in this Agreement.

 

      F. The parties   acknowledge   that Dr. Chaudhuri had the right to acquire a

majority   interest in the   Company,   which   right he has agreed   (subject to the

conditions   herein) to rescind,   and accept in its place stock purchase warrants

in favor of Dr.   Chaudhuri   and Thomas to acquire only up to (and not to exceed)

24.9% of the Company's capital stock, which warrants are not exercisable for two

years from the date of   issuance,   and the   Company   and   OC-PIN are   willing to

consent to this arrangement.

 

      G. The   Company is a party to a   definitive   Asset Sale   Agreement,   dated

September 29, 2004 (the "ASSET SALE   AGREEMENT"),   pursuant to which the Company

has agreed to purchase four   hospitals   from   subsidiaries   of Tenet   Healthcare

Corporation   located in Orange   County,   California,   known as   Western   Medical

Center - Santa   Ana,   Western   Medical   Center   -   Anaheim,   Costal   Communities

Hospital,   and Chapman Medical Center.   The transactions   contemplated under the

Asset   Sale   Agreement   are   collectively   referred   to   herein   as   the   "TENET

TRANSACTION".

 

 

                                       1

<PAGE>

 

      H. The Tenet   Transaction   has not yet closed,   and the parties   desire to

reflect and memorialize   certain   understandings   among them with respect to the

Tenet   Transaction.    This   Agreement   is   expressly   conditioned   upon   Tenet's

acceptance of the   restructuring   contemplated by this Agreement and its release

of Dr. Chaudhuri from his guarantee of the Chapman lease.

 

                                A G R E E M E N T

 

      In   consideration   of the   foregoing   premises,   the mutual   covenants and

agreements set forth herein, and for other good and valuable consideration,   the

receipt   and   sufficiency   of which are   hereby   acknowledged,   and   subject   to

satisfaction of the conditions set forth in Section 9, the parties hereto hereby

agree as follows:

 

      1. DEFINITIONS.   For the purposes of this Agreement (including   amendments

to the Purchase   Agreement   contained   herein),   (i) unless   otherwise set forth

herein,   capitalized   terms or matters of construction   deemed or established in

the Purchase Agreement, as amended hereby, shall be applied herein as defined or

established therein,   and (ii) the term   "FULLY-DILUTED"   includes all shares of

Common Stock of the Company issued and   outstanding at the date in question plus

all shares of Common   Stock of the Company   issuable   (whether or not vested) at

that date upon full exercise of all options, warrants or other rights to acquire

Common Stock of the Company and full   conversion of all   securities   convertible

into   Common   Stock   of the   Company,   but   excluding   from   that   amount   up to

10,000,000   shares   (or rights to   acquire   shares) of Common   Stock per year to

employees,   consultants,   officers or directors of the Company pursuant to stock

option or restricted   stock plans or agreements   approved by the Company's Board

of Directors.

 

      2.   RESCISSION   AND   CANCELLATION   OF   NOTES,   OPTION,    NON-CIRCUMVENTION

AGREEMENT AND CERTAIN PROVISIONS OF PURCHASE AGREEMENT.

 

            (a) Upon   fulfillment   of the conditions set forth in Section 9, the

Convertible   Note,   the   Secured   Note,   the   Stock   Option   Agreement   and   the

Non-Circumvention   Agreement are hereby   rescinded and canceled.   Within two (2)

business days after receipt of the $10,000,000 plus accrued interest referred to

in Section 6, Dr.   Chaudhuri   shall, and he shall cause his attorneys and agents

to, (i) return to the   Company the   originals   of the   Convertible   Note and the

Secured Note for   cancellation and (ii) deliver to OC-PIN copies of all material

agreements   executed by Dr. Chaudhuri with the Company or in connection with the

Tenet Transaction.   Except as provided in this Agreement with respect to Thomas,

Dr.   Chaudhuri   hereby   represents   and warrants to the Company that he has not,

directly   or   indirectly,   transferred,   sold   or   syndicated   any   part   of the

securities that he received or was entitled to acquire from the Company.

 

            (b) The Purchase Agreement is hereby rescinded and canceled,   except

that the   provisions   of: (i)   Section 1.7   thereof   shall   remain in effect (as

amended by Section 4 below) (ii)   Article II thereof   shall remain in effect (as

amended   by   Section   4 below)   and   shall be   applicable   to the   shares of the

Company's Common Stock issuable pursuant to the warrants   described in Section 3

below;   (iii)   Articles   III and IV   thereof   shall   remain   in   effect   and the

provisions   thereof   shall be   deemed to apply   with   respect   to the   issuances

described   in Section 3 below;   and (iv)   Section   5.3 thereof   shall   remain in

effect for the benefit of both Dr. Chaudhuri and Thomas for so long as either of

them holds either stock purchase warrants pursuant to the new warrants described

in Section 3 below or shares of the Company's Common Stock obtained by them upon

exercise   thereof,   provided,   however that (A) Section 5.3 shall   terminate and

cease to have effect upon an   acquisition   of the Company by an unrelated   third

party   and (B)   each of Dr.   Chaudhuri   and   Thomas   shall   execute   appropriate

confidentiality   agreements   in   customary   form   with   respect   to   information

obtained pursuant to these sections.

 

 

                                       2

<PAGE>

 

            (c) Dr.   Chaudhuri   agrees to reasonably   cooperate with the Company

and   California   Department   of Health   Services   at no or   minimal   cost to Dr.

Chaudhuri by providing   information and other reasonable   assistance so that the

Company may promptly   complete the Tenet Transaction and obtain licensing of the

hospital facilities to be acquired therein; provided that such cooperation shall

not result in any material modification to this Agreement.

 

      3.   ISSUANCE OF NEW   NON-CONVERTIBLE   NOTES AND   WARRANTS;   ASSIGNMENT   TO

THOMAS.    The   Company   has   agreed   to   issue   to   Dr.    Chaudhuri   (i)   a   new

non-convertible secured promissory note reflecting amounts loaned to the Company

by Dr. Chaudhuri as well as expenditures   made by Dr. Chaudhuri on the Company's

behalf or for the Company's   benefit,   plus accrued interest to date, and (ii) a

new   stock   purchase   warrant   reflecting   the right to   purchase   shares of the

Company's   Common Stock.   Dr.   Chaudhuri   has assigned to Thomas   certain of his

rights with respect thereto,   to which assignments the Company and OC-PIN hereby

consent. As a result of the assignment,   the parties acknowledge and agree that,

within 48 hours after the execution of this   Agreement,   but dated and effective

as of the date of this Agreement, the Company shall issue to (A) Dr. Chaudhuri a

non-convertible   secured   promissory note, in substantially   the form of Exhibit

A-1, and in a principal   amount equal to 80% of the sum of all amounts loaned by

Dr.   Chaudhuri to the Company or paid,   advanced or incurred by Dr. Chaudhuri on

behalf or for the benefit of the   Company,   or in   connection   with the Purchase

Agreement and related   documents,   or in connection   with the Tenet   Transaction

(collectively,   the "ADVANCES"), (B) Thomas a non-convertible secured promissory

note, in substantially   the form of Exhibit A-2, and in a principal amount equal

to 20% of the Advances   (collectively,   the "NEW   NOTES"),   (C) Dr.   Chaudhuri a

stock purchase warrant   reflecting the right to purchase up to 60,000,000 shares

of the   Company's   Common   Stock   (but   not   to   exceed   20%   of   the   Company's

Fully-Diluted   capital stock) in   substantially   the form of Exhibit B-1 and (D)

Thomas   a   stock   purchase   warrant   reflecting   the   right   to   purchase   up to

14,700,000   shares of the Company's   Common Stock (but not to exceed 4.9% of the

Company's   Fully-Diluted capital stock) in substantially the form of Exhibit B-2

(collectively,   the   "NEW   WARRANTS").   Repayment   of the   New   Notes   shall   be

guaranteed by OC-PIN pursuant to a General Continuing Guaranty   substantially in

the form of Exhibit C.

 

      4. CERTAIN AMENDMENTS.

 

            (a)   Section   1.7 of the   Purchase   Agreement   is hereby   amended by

deleting it in its entirety and replacing it with the following:

 

 

                                       3

<PAGE>

 

            "1.7 PRE-EMPTIVE RIGHTS.

 

                  1.7.1 GENERAL   PRE-EMPTIVE RIGHT.   Provided that Purchaser and

            William E. Thomas   ("THOMAS")   have   exercised   their Stock Purchase

            Warrants   dated   January   17,   2005,   the Company   hereby   grants to

            Purchaser and Thomas a right of first refusal with respect to future

            sales   by   the   Company   of   its   equity   securities   or   securities

            convertible   into   or   exercisable   for   equity   securities,    where

            issuance of those securities would result in dilution of Purchaser's

            and   Thomas's   combined   equity   position   to less than 24.9% of the

            Common Stock of the Company on a Fully-Diluted   basis. Each time the

            Company   proposes to offer any shares of, or securities   convertible

            into or   exercisable   for any shares of, any class of the   Company's

            equity   securities   which   would   reduce   Purchaser's   and   Thomas's

            combined   equity   position   to below 24.9% (the "NEW   SHARES"),   the

            Company   shall first make an offer to   Purchaser   and Thomas of such

            portion of the New   Shares   which   would   maintain   Purchaser's   and

            Thomas's   combined   equity   position at a minimum of 24.9% (the "PRO

            RATA   SHARE").   The   closing of the sale of the Pro Rata Share shall

            occur   simultaneously   with   the   sale of the New   Shares   to   other

            investors,   and the Pro   Rata   Share   shall be   priced   equal to the

            lowest price paid by any of the other   investors,   including any who

            may be   purchasing   New Shares by virtue of similar   pre-emptive   or

            other purchase rights.

 

                  1.7.2 TAG-ALONG   RIGHT RELATING TO OC-PIN.   The Company hereby

            grants to   Purchaser   and   Thomas a purchase   right with   respect to

            future   issuances by the Company of any of its securities to Anil V.

            Shah,   M.D.   or Orange   County   Physicians   Investment   Network,   or

            affiliates of either of them (collectively,   "OC-PIN GROUP"),   where

            the issuance of such additional   shares of Common Stock would result

            in the OC-PIN Group having been issued, in the aggregate,   more than

            187,240,000   shares of the Company's Common Stock on a Fully-Diluted

            basis (as adjusted for any stock splits, dividends,   combinations or

            the like).   Upon   satisfaction   of these   conditions,   Purchaser and

            Thomas   shall   have the   right to   acquire,   for a period of 90 days

            following   notification   by the Company to Purchaser and Thomas that

            the   pre-emptive   right is   triggered   (which   notice shall be given

            within 10 business days of such trigger),   the same securities,   and

            at the same price, as the member of the OC-PIN Group   purchasing the

            Company's   securities,    in   an   amount   that   represents   the   same

            proportion   as   Purchaser's   and Thomas's   combined   holdings of the

            Company's Common Stock on a Fully-Diluted   basis bears to the OC-PIN

            Group's   combined   holdings   of   the   Company's   Common   Stock   on a

            Fully-Diluted basis immediately prior to the issuance in question.

 

                  1.7.3 EXCLUSIONS.   The rights in this Section 1.7 shall not be

            applicable to the issuance or sale of (i) securities issued pursuant

            to stock splits,   stock   dividends,   or similar   transactions;   (ii)

            shares of Common Stock issued to employees, consultants, officers or

            directors   of   the   company    pursuant   to   stock   option   plans   or

            restricted stock plans or agreements approved by the Company's Board

            of Directors;   (iii) securities issued to financial   institutions or

            lessors in connection with commercial credit arrangements, equipment

            financings,   commercial   property   lease   transactions,   or   similar

             transactions   approved   by the   Board of   Directors   and not for the

            purpose of raising capital, (iv) shares of Common Stock issued in an

            underwritten public offering; or (v) securities issued in connection

            with bona fide   acquisition   transactions   approved   by the Board of

            Directors.

 

 

                                       4

<PAGE>

 

                  1.7.4 TERMINATION.   The pre-emptive rights in this Section 1.7

            shall terminate and cease to have effect upon the earlier of (i) the

            closing of an acquisition of the Company to an unrelated third party

            or (ii) the later of   one-half   (3 1/2)   years from the date of this

            Agreement   or the   termination   of any   similar   pre-emptive   rights

            granted to OC-PIN or its affiliates."

 

            (b)   Article   II of the   Purchase   Agreement   is hereby   amended   to

reflect   that   references   to   "Purchaser"   or "the   Holder"   shall now mean Dr.

Chaudhuri and Thomas.   The definition of "REGISTRABLE   SECURITIES"   contained in

Section 2.1 of the   Purchase   Agreement   is hereby   deleted in its   entirety and

replaced with the following:

 

            "`REGISTRABLE SECURITIES' means, collectively,   any shares of common

             stock of the Company issued to Kali P. Chaudhuri, M.D. or William E.

            Thomas    pursuant   to   Stock   Purchase    Warrants   issued   to   those

            individuals   on   January   17,   2005,   and any   securities   issued or

            issuable   upon any stock   dividend,   stock split,   recapitalization,

            merger,   consolidation   or similar event with respect to such shares

            of common stock. As to any particular Registrable   Securities,   such

            securities   shall   cease   to be   Registrable   Securities   when (i) a

            registration   statement   covering such securities   shall have become

            effective   under the 1933 Act and such   securities   shall   have been

            disposed of in accordance   with such   registration   statement,   (ii)

            such securities   shall have been   distributed to the public,   or all

            such securities may be sold publicly without registration,   pursuant

            to Rule 144 or Rule 144A (or any   successor   provisions   ) under the

            1933   Act,   or   (iii)   such   securities   shall   have   ceased   to   be

            outstanding."

 

      5. AMENDMENT OF SECURITY   AGREEMENT.   The Security   Agreement   between the

Company and Dr. Chaudhuri dated September 28, 2004, is hereby amended to provide

that the secured parties are Dr. Chaudhuri and Thomas,   and that the obligations

secured are the obligations under the New Notes and any other obligations of the

Company to Dr. Chaudhuri   arising   thereunder or under this Agreement;   however,

the security   interest   securing the New Notes shall be terminated   effective at

the closing of the Tenet   Transaction.   Dr.   Chaudhuri (and Thomas if necessary)

shall   execute   and,   if   requested   by the   Company and the lender in the Tenet

Transaction,   deliver to the escrow agent for the Tenet   Transaction an executed

UCC termination statement to accomplish the foregoing.

 

 

                                       5

<PAGE>

 

      6. PAYMENT TO DR. CHAUDHURI;   CERTAIN DISCLAIMERS. On the date of approval

of this   Agreement by Tenet as   contemplated   by Section 9, OC-PIN shall pay, or

shall cause the   Company to pay,   or shall cause to be released   from the Escrow

Fund, $10,000,000 plus the accrued interest in the Escrow Fund to Dr. Chaudhuri,

in immediately available funds. Nothing in this Agreement or any of the exhibits

hereto shall be effective   or of any force and effect   until Dr.   Chaudhuri   has

received this payment of $10,000,000   plus accrued   interest.   Any agreements or

arrangements   between   OC-PIN and the Company   with   respect to this   payment of

$10,000,000   plus   accrued   interest   shall be pursuant to a separate   agreement

between   them,   and   Dr.   Chaudhuri   shall   have   no   involvement   therewith   or

responsibility therefor.   Furthermore,   Dr. Chaudhuri makes, and the Company and

OC-PIN expressly   acknowledge that Dr. Chaudhuri has made, no representations or

warranties   to OC-PIN or the Company or any of their   affiliates   regarding   the

Company,   OC-PIN,   OC-PIN's financial   wherewithal,   the Tenet Transaction,   the

financing   related to the Tenet   Transaction (or the Company's ability to obtain

it),   licensing   (or the   Company's   ability to obtain   it) or any other   matter

relating in any way to OC-PIN's   investment in or other   financial   arrangements

with the   Company.   Each of the Company and OC-PIN has done its own   independent

investigation   of the other,   and is fully   satisfied   with the results of those

investigations.   The Company and OC-PIN   hereby agree to   indemnify,   defend and

hold Dr. Chaudhuri   harmless from and against any claims,   liabilities or losses

incurred by either of them as a result of the   financial   or other   arrangements

between them.

 

      7.   AMENDMENT   AND EXERCISE OF AMENDED AND RESTATED   REAL ESTATE   PURCHASE

OPTION.   Pursuant to Section 3 of the Option Agreement dated September 28, 2004,

as amended and   restated on November   16,   2004 ("LLC   OPTION   AGREEMENT"),   Dr.

Chaudhuri   currently has an option to purchase 100% of the membership   interests

of the LLC (as   defined in the LLC Option   Agreement)   for   $5,000,000.   The LLC

Option Agreement is hereby amended to provide that Dr.   Chaudhuri's option shall

be to purchase 49% of the membership   interests of the LLC for   $2,450,000,   and

may be assigned to and exercised by an affiliate of Dr. Chaudhuri. Dr. Chaudhuri

hereby   exercises   that option,   as so amended,   such exercise to be conditioned

upon, and effective at, the Closing (as defined in the Asset Sale   Agreement) of

the Tenet Transaction.   The exercise is also conditioned upon (a) receipt by Dr.

Chaudhuri   of receipt of evidence   satisfactory   to him that OC-PIN has acquired

the   remaining   51% of the LLC   membership   interests   simultaneously   with   Dr.

Chaudhuri's   acquisition   of the 49% interest,   (b) receipt by Dr.   Chaudhuri of

receipt   of   evidence   satisfactory   to him that the LLC has   acquired   the real

estate (owned in fee) in the Tenet   Transaction   (i.e.   Western Medical Center -

Santa Ana, Western Medical Center - Anaheim and Coastal   Community   Hospital and

the medical office   buildings,   but not the leased Chapman   Hospital and medical

office building),   (c) execution by Dr.   Chaudhuri,   OC-PIN and Dr. Shah, and by

the Company if initially   required,   of a customary   Operating   Agreement   for a

California   manager-managed limited liability company reasonably satisfactory to

Dr.   Chaudhuri   and OC-PIN in which (i) Dr.   Chaudhuri   and Dr.   Shah have equal

rights of management of the LLC, and (ii) Dr. Chaudhuri may not sell,   syndicate

or   otherwise   transfer   any of his   management   rights in the LLC   without   the

consent of the holder(s) of a majority of the LLC membership interests (although

it is   expressly   understood   that   Dr.   Chaudhuri   may   hold   title   to the LLC

membership interests through an affiliate), and (d) execution by the Company, as

tenant,   of a lease with the LLC,   as   landlord,   in   substantially   the form of

Exhibit D. The exercise   price shall be placed into escrow and released   against

delivery   of   certificates   or other   satisfactory   evidence   of transfer to Dr.

Chaudhuri   or an affiliate   of 49% of the   membership   interests of the LLC. The

Company and OC-PIN   agree to comply with all of the   aforesaid   covenants   which

may,   at Dr.   Chaudhuri's   election,   be   specifically   enforced   as provided in

Section 11.6.

 

 

                                       6

<PAGE>

 

      8. CERTAIN   AGREEMENTS RELATED TO TENET TRANSACTION AND RELATED FINANCING.

The parties have agreed as follows with respect to the Tenet Transaction and the

proposed $80,000,000 credit facility ("FACILITY") from Company's current Lender,

or other lender agreeable to the parties ("LENDER") related thereto:

 

            (a) The Company and the LLC shall be   co-borrowers   with   respect to

the   Facility,   with the   Company   and the LLC each fully   liable for the entire

amount borrowed thereunder.

 

            (b) The   Company   and the LLC will enter into a mutually   acceptable

inter-borrower and cross-indemnity agreement.

 

             (c) If   requested   by the   Lender,   the Lender   will have a security

interest   not only in all of the assets of the Company and the LLC,   but also in

all   LLC   membership   interests   and in the   master   lease   from   the LLC to the

Company.

 

      9. CONDITIONS PRECEDENT.   This Agreement, and specifically Dr. Chaudhuri's

and Thomas's   obligations   hereunder,   are   expressly   conditioned   upon Tenet's

acceptance of the restructuring   and other terms set forth herein,   and, because

Dr.   Chaudhuri   is   rescinding   his right to receive any interest in the Chapman

Hospital   real estate,   upon   Tenet's   release of Dr.   Chaudhuri's   guarantee in

Tenet's favor of the tenant's   obligations under the Chapman Hospital lease. Dr.

Shah shall provide his personal   guarantee of the tenant's   obligations in place

of   that of Dr.   Chaudhuri,   in a for   substantially   identical   to the   form of

guaranty   provided by Dr.   Chaudhuri to Tenet. The provisions of this Agreement,

including the exhibits   hereto,   shall only be effective upon (i) receipt by Dr.

Chaudhuri of written   evidence   reasonably   satisfactory to him, and executed by

Tenet,   setting forth Tenet's   acceptance and release as described   above,   (ii)

receipt by Dr.   Chaudhuri of the payment of   $10,000,000   plus accrued   interest

referred   to in Section 6, (iii)   receipt by Dr.   Chaudhuri   and Thomas of fully

executed   originals of the New Notes and New   Warrants,   and (iv)   execution and

delivery of a mutually   agreeable   Operating   Agreement   for the LLC pursuant to

Section 7 above.   If all of the foregoing   conditions are not fully satisfied by

5:00 p.m. on January 31, 2005, Dr. Chaudhuri shall be entitled to terminate this

Agreement,   in which case nothing in this Agreement,   including all rescissions,

amendments and restructurings, shall be of any force or effect.

 

      10.   MUTUAL   RELEASE.   Except with   respect to   obligations   created in or

expressly   continued   by this   Agreement   and in the New Warrants and New Notes,

each of Dr.   Chaudhuri and Thomas,   on the one hand, and the Company and OC-PIN,

on the other hand, on behalf of   themselves   and their   successors   and assigns,

hereby   release   and   discharge   the   other   and   the   other's   representatives,

officers, directors, agents, employees,   attorneys,   successors and assigns from

any claims,   demands,   actions,   causes of action, losses and liabilities of any

kind or nature   whatsoever that the party may have, may have had in the past, or

may have in the future, whether known or unknown, suspected or unsuspected,   now

due or contingent, to the full extent that any such claim, demand, action, cause

of   action,   loss or   liability   arises   out of or is in any way   related to the

Purchase   Agreement,   the   Convertible   Note, the Secured Note, the Stock Option

Agreement,   the Tenet   Transaction or OC-PIN's   investment in or other financial

arrangements   with the   Company.   Each of the parties   hereby   acknowledges   and

agrees that he or it is aware of, has read,   has had   explained   to him or it by

independent counsel of his or its own choosing,   understands,   and hereby waives

the provisions of California Civil Code Section 1542, which reads:

 

 

                                       7

<PAGE>

 

            A general   release does not extend to claims which the creditor does

            not know or suspect   to exist in his favor at the time of   executing

            the release,   which,   if known by him must   materially have affected

            his settlement with the debtor.

 

Dr.   Chaudhuri   also   agrees to release   the   individual   members of the Medical

Staff,   as that term is defined in the   Agreement   dated as of January   25, 2005

among   the   Company,   Dr.   Chaudhuri,   Chapman   Medical   Center,   Inc.,   Coastal

Communities Hospital, Inc.; WMCA, Inc. and WMC-SA, Inc. and the Medical Staff of

Western Medical Center - Santa Ana, an   unincorporated   association   (the "STAFF

AGREEMENT"),   as   more   specifically   set   forth   in   Section   11 of   the   Staff

Agreement.

 

      11. MISCELLANEOUS.

 

            11.1   AMENDMENT.   This   Agreement may be modified or amended only by

mutual written agreement of the parties. Any such modification or amendment must

be in writing, dated and signed by the parties and attached to this Agreement.

 

            11.2 BINDING EFFECT. Subject to the foregoing,   this Agreement shall

be binding on and shall inure to the benefit of the parties and their respective

successors and assigns.

 

            11.3 ATTORNEYS' FEES. In any action or dispute, at law or in equity,

that may arise under or otherwise relate to this Agreement, the prevailing party

shall be   entitled   to the award of   reasonable   attorneys'   fees and costs,   in

addition   to whatever   relief the   prevailing   party may be   awarded;   provided,

however,   that so long as the   present   Company   Board of   Directors   remains in

place,   the   parties   agree to bear their own fees and costs in the event of any

dispute.

 

            11.4 VENUE.   The parties agree that Orange County,   California shall

be the only proper venue for disputes related to this Agreement.

 

            11.5 ENTIRE AGREEMENT. This Agreement, along with the New Notes, New

Warrants and General   Continuing   Guaranty,   and the Purchase   Agreement and the

Security Agreement,   as amended hereby,   represents the entire understanding and

agreement of the parties regarding its subject matter,   and supersedes any prior

oral or   written   agreements,   representations,   understandings   or   discussions

between the parties. No other understanding between the parties shall be binding

on them   unless set forth in writing   and signed by the party   against   whom the

understanding is to be enforced.

 

            11.6   SPECIFIC   PERFORMANCE.   The parties   acknowledge   that the LLC

membership   interests,   the real estate to be acquired by the LLC, the New Notes

and the New   Warrants   are   unique,   and that   damages   would not be an adequate

remedy for Dr.   Chaudhuri   and Thomas in the event of the   Company's or OC-PIN's

failure to perform any of their obligations hereunder and under the New Warrants

(including,   without   limitation,   its   obligation   to deliver the Shares if Dr.

Chaudhuri   or Thomas   elects to   exercise   his New   Warrant).   As a result,   the

parties   agree that this   Agreement   may be   enforced   by any party by   specific

performance.

 

 

                                       8

<PAGE>

 

            11.7 GOVERNING LAW. This Agreement   shall be construed in accordance

with and governed by the laws of the State of   California,   except the conflicts

of laws   provisions   that would require the application of the laws of any other

jurisdiction.

 

            11.8 HEADINGS.   The headings in this   Agreement are intended   solely

for convenience of reference and shall be given no effect in the construction or

interpretation of this Agreement.

 

            11.9 MEANING OF CERTAIN WORDS. Wherever the context may require, any

pronouns   used in this   Agreement   shall   include the   corresponding   masculine,

feminine,   or neuter   forms,   and the singular   form of nouns shall   include the

plural and vice versa.

 

            11.10 NO THIRD-PARTY   BENEFICIARY   RIGHTS. The parties do not intend

to confer   and this   Agreement   shall not be   construed   to confer any rights or

benefits to any person, firm, corporation or entity other than the parties.

 

             11.11 NOTICES.   All notices or communications   required or permitted

under this Agreement shall be given in writing and delivered   personally or sent

by United States   registered or certified   mail with postage   prepaid and return

receipt requested or by overnight delivery service (e.g., Federal Express, DHL).

Notice shall be deemed given when sent, if sent as specified in this Section, or

otherwise deemed given when received. In each case, notice shall be delivered or

sent to:

 

         IF TO COMPANY, ADDRESSED TO:

         Integrated Healthcare Holdings, Inc.

         695 Town Center Drive, Suite 260

         Costa Mesa, CA 92626

         Attention: Chief Executive Officer

 

         IF TO DR. CHAUDHURI OR TO THOMAS, ADDRESSED TO:

         c/o Strategic Global Management, Inc.

         6800 Indiana Avenue, Suite 130

         Riverside, CA 92506

         Attention: William E. Thomas, Esq.

 

         IF TO DR. SHAH OR TO OC-PIN, ADDRESSED TO:

         c/o Orange County Physicians Investment Network, LLC

         2621 S. Bristol Street, Suite 108

         Santa Ana, CA 92704

         Attention: Anil V. Shah, Manager

 

            11.12 SEVERABILITY. If any provision of this Agreement is determined

to be illegal   or   unenforceable,   that   provision   shall be   severed   from this

Agreement,   and such severance shall have no effect upon the   enforceability   of

the remainder of this Agreement.

 

 

                                       9

<PAGE>

 

            11.13   WAIVER.   No delay or failure to   require   performance   of any

provision of this   Agreement   shall   constitute a waiver of that provision as to

that or any other instance.   Any waiver granted by a party must be in writing to

be effective, and shall apply solely to the specific instance expressly stated.

 

            11.14 CONFIDENTIALITY. Neither party shall disclose any of the terms

of this   Agreement   to any   person   or   entity   (other   than   its   attorneys   or

accountants)   without the prior written   consent of the other party,   unless and

only to the extent such disclosure is required by law, including the 1933 Act.

 

            11.15 DISPUTE RESOLUTION. In the event of any dispute arising out of

or   relating   to this   Agreement,   such   dispute   shall be   resolved   solely and

exclusively by confidential binding arbitration with the Orange County branch of

JAMS ("JAMS") to be governed by JAMS'   Commercial Rules of Arbitration in effect

at the time of the   commencement of the arbitration (the "JAMS RULES") and heard

before   one   arbitrator.   The   parties   shall   attempt   to   mutually   select the

arbitrator. In the event they are unable to mutually agree, the arbitrator shall

be selected by the procedures prescribed by the JAMS Rules.

 

            11.16   COUNTERPARTS.   This   Agreement may be executed in one or more

counterparts,   each of which shall be deemed to be an original, and all of which

together shall constitute one and the same instrument.

 

                                      * * *

 

                         [SIGNATURES ON FOLLOWING PAGE]

 

 

                                        10

<PAGE>

 

      IN WITNESS   WHEREOF,   the parties   hereto have caused this Agreement to be

executed and delivered as of the date first written above.

 

THE COMPANY:                            INTEGRATED HEALTHCARE HOLDINGS,

                                        INC., a Nevada corporation

 

 

                                       By:       /s/ Larry B. Anderson

                                           -------------------------------------

                                             Larry B. Anderson, President

 

 

DR. CHAUDHURI:                               /s/ Kali P. Chaudhuri

                                       -----------------------------------------

                                       KALI P. CHAUDHURI, M.D.

 

 

OC-PIN:                                 ORANGE COUNTY PHYSICIANS

                                       INVESTMENT NETWORK, LLC, a Nevada

                                       limited liability company

 

 

                                       By:   /s/ Anil V. Shah

                                           -------------------------------------

                                            Anil V. Shah, M.D., Manager

 

For purposes of Sections 3 and 10 only:

 

I hereby   accept the   assignment of a portion of Dr.   Chaudhuri's   rights as set

forth in Section 3, and agree to be bound by the   provisions of a Stock Purchase

Warrant   substantially   in the form   attached   hereto as Exhibit B-2, and by the

provisions of Section 10. Except as expressly set forth above,   I am not a party

to this Agreement and have given no representations, warranties or assurances to

any person.

 

 

THOMAS:                                   /s/ William E. Thomas

                                       -----------------------------------------

                                        WILLIAM E. THOMAS

 

For purposes of Sections 2(a) and 9 only:

 

I hereby agree to the rescission of the Non-Circumvention Agreement on the terms

and conditions set forth in Section 2(a), and to providing a personal   guarantee

as set forth in Section 9. Except as expressly set forth above, I am not a party

to this Agreement and have given no representations, warranties or assurances to

any person.

 

 

DR. SHAH                                  /s/ Anil V. Shah

                                        -----------------------------------------

                                       ANIL V. SHAH, M.D.

 

 

                                       11

<PAGE>

 

Approved as to form:

 

 

----------------------------------------

Gregg Amber, Esq. of Rutan & Tucker, LLP

attorneys for Dr. Chaudhuri

 

 

----------------------------------------

Allen Z. Sussman, Esq. of Morrison &

Foerster, LLP

attorneys for the Company

 

 

----------------------------------------

Hari S. Lal, Esq. of The Lal Law Firm,

Inc.

attorneys for Dr. Shah and OC-PIN

 

 

                                       12

<PAGE>

 

                                   EXHIBIT A-1

 

                                     FORM OF

                              NON-CONVERTIBLE NOTE

 

$__________                                                 Costa Mesa, California

                                                                January 27, 2005

 

                             SECURED PROMISSORY NOTE

 

      FOR VALUE RECEIVED, the undersigned, INTEGRATED HEALTHCARE HOLDINGS, INC.,

a Nevada   corporation (the   "COMPANY"),   promises to pay to the order of Kali P.

Chaudhuri,   M.D.   ("HOLDER"),   at c/o 6800 Indiana Avenue, Suite 130, Riverside,

California   92506,   or at such   other   location   as is   designated   by Holder in

writing hereunder,   the aggregate sum of   ________________   Dollars   ($_______),

bearing simple interest on the unpaid   principal   balance of this Note, from the

date of this   Note   until   this   Note is paid in full at a rate of five   percent

(5.0%) per annum.   Accrued interest shall be computed based on the actual number

of days   elapsed.   Interest   only shall be payable on the first   Business Day of

each calendar   month   beginning   February 1, 2005. All principal and accrued but

unpaid   interest   will be due and   payable   in full at the   Closing of the Tenet

Transaction,   or on   demand at any time   after   February   28,   2005 if the Tenet

Transaction has not closed by that date (the "DUE DATE").   All payments shall be

made in   lawful   money of the   United   States,   without   offset,   deduction,   or

counterclaim of any kind.

 

      1.   TERMS.   Capitalized   terms used   herein   without   definition   have the

meanings   ascribed   to   them in the   Rescission,   Restructuring   and   Assignment

Agreement   of even date   herewith by and among the   Company,   Holder and certain

other parties thereto.

 

      2 PAYMENTS   AND   COMPUTATIONS.   All   payments   on account of   indebtedness

evidenced by this Note shall be made not later than 11:00 A.M. (California time)

on the day when due in   lawful   money of the   United   States   and shall be first

applied to interest due on the unpaid principal balance and the remainder to any

principal   due.   Payments   are to be made at such   place as   Holder or any legal

holder of this   Note may,   from time to time,   in   writing   specify,   and in the

absence of a specification,   at the principal place of business of Holder as set

forth in the first   paragraph   of this Note.   The   Company   may pre-pay the full

amount of all   principal   of and   accrued   interest   under this Note at any time

without premium or penalty.

 

      3. SECURITY.   Repayment of this Note is secured pursuant to the terms of a

Security   Agreement   dated September 28, 2004, and is guarantied by a Continuing

General Guaranty dated January 27, 2005 by Orange County   Physicians   Investment

Network, LLC.

 

      4.   ATTORNEYS'   FEES.   If any   action   is   instituted   on this   Note,   the

successful   or   prevailing   party   or   parties   shall   be   entitled   to   recover

reasonable    attorneys'   fees   and   other   costs   incurred   in   that   action   or

proceeding, in addition to any other relief to which the party or parties may be

entitled.   Diligence,   demand, presentment,   notice of dishonor, and protest are

waived   by the   Company,   and any   and all   makers,   sureties,   guarantors,   and

endorsers of this Note, and their successors and assigns. Time is of the essence

for every obligation under this Note.

 

 

                                       1

<PAGE>

 

      6.   LAW.   This   Note   shall be   construed   under   the laws of the State of

California,   as such laws are applied to contracts   entered   into and   performed

entirely within that state by residents thereof.

 

      7. RULES OF   CONSTRUCTION/REPRESENTATION.   The parties agree that they are

sophisticated   business   persons or entities who have had the   opportunity to be

represented   by counsel during the   negotiation   and execution of this Note and,

therefore,   waive the   application   of any law,   regulation,   holding or rule of

construction   providing that   ambiguities in an agreement or other document will

be construed against the party drafting such agreement or document.

 

      8.   DISPUTE   RESOLUTION.   In the event of any   dispute   arising   out of or

relating to this Note,   such dispute shall be resolved solely and exclusively by

confidential   binding arbitration with the Orange County branch of JAMS ("JAMS")

to be governed by JAMS' Commercial Rules of Arbitration in effect at the time of

the   commencement   of the   arbitration   (the "JAMS   RULES") and heard before one

arbitrator.   The parties shall attempt to mutually select the arbitrator. In the

event they are unable to mutually agree, the arbitrator shall be selected by the

procedures   prescribed   by the   JAMS   Rules.   Each   party   shall   bear   its   own

attorneys' fees,   expert witness fees, and costs incurred in connection with any

arbitration.

 

      IN WITNESS WHEREOF, the Company has executed and delivered this Note as of

the day and year and at the place first above written.

 

                                        INTEGRATED HEALTHCARE HOLDINGS, INC.

 

                                       By:

                                          --------------------------------------

                                              Larry B. Anderson, President

 

 

                                       2

<PAGE>

 

                                   EXHIBIT A-2

 

                                     FORM OF

                              NON-CONVERTIBLE NOTE

 

$__________                                                 Costa Mesa, California

                                                                January 27, 2005

 

                             SECURED PROMISSORY NOTE

 

      FOR VALUE RECEIVED, the undersigned, INTEGRATED HEALTHCARE HOLDINGS, INC.,

a Nevada corporation (the "COMPANY"), promises to pay to the order of William E.

Thomas ("HOLDER"), at c/o 6800 Indiana Avenue, Suite 130, Riverside,   California

92506,   or at   such   other   location   as is   designated   by   Holder   in   writing

hereunder,   the aggregate sum of ________________   Dollars   ($_______),   bearing

simple interest on the unpaid   principal   balance of this Note, from the date of

this Note until this Note is paid in full at a rate of five   percent   (5.0%) per

annum.   Accrued   interest   shall be computed   based on the actual number of days

elapsed.   Interest   only   shall be   payable   on the first   Business   Day of each

calendar month beginning   February 1, 2005. All principal and accrued but unpaid

interest   will   be due   and   payable   in   full   at   the   Closing   of   the   Tenet

Transaction,   or on   demand at any time   after   February   28,   2005 if the Tenet

Transaction has not closed by that date (the "DUE DATE").   All payments shall be

made in   lawful   money of the   United   States,   without   offset,   deduction,   or

counterclaim of any kind.

 

      1.   TERMS.   Capitalized   terms used   herein   without   definition   have the

meanings   ascribed   to   them in the   Rescission,   Restructuring   and   Assignment

Agreement   of even date   herewith by and among the   Company,   Holder and certain

other parties thereto.

 

      2 PAYMENTS   AND   COMPUTATIONS.   All   payments   on account of   indebtedness

evidenced by this Note shall be made not later than 11:00 A.M. (California time)

on the day when due in   lawful   money of the   United   States   and shall be first

applied to interest due on the unpaid principal balance and the remainder to any

principal   due.   Payments   are to be made at such   place as   Holder or any legal

holder of this   Note may,   from time to time,   in   writing   specify,   and in the

absence of a specification,   at the principal place of business of Holder as set

forth in the first   paragraph   of this Note.   The   Company   may pre-pay the full

amount of all   principal   of and   accrued   interest   under this Note at any time

without premium or penalty.

 

      3. SECURITY.   Repayment of this Note is secured pursuant to the terms of a

Security   Agreement   dated September 28, 2004, and is guarantied by a Continuing

General Guaranty dated January 27, 2005 by Orange County   Physicians   Investment

Network, LLC.

 

      4.   ATTORNEYS'   FEES.   If any   action   is   instituted   on this   Note,   the

successful   or   prevailing   party   or   parties   shall   be   entitled   to   recover

reasonable    attorneys'   fees   and   other   costs   incurred   in   that   action   or

proceeding, in addition to any other relief to which the party or parties may be

entitled.   Diligence,   demand, presentment,   notice of dishonor, and protest are

waived   by the   Company,   and any   and all   makers,   sureties,   guarantors,   and

endorsers of this Note, and their successors and assigns. Time is of the essence

for every obligation under this Note.

 

 

                                       1

<PAGE>

 

      6.   LAW.   This   Note   shall be   construed   under   the laws of the State of

California,   as such laws are applied to contracts   entered   into and   performed

entirely within that state by residents thereof.

 

      7. RULES OF   CONSTRUCTION/REPRESENTATION.   The parties agree that they are

sophisticated   business   persons or entities who have had the   opportunity to be

represented   by counsel during the   negotiation   and execution of this Note and,

therefore,   waive the   application   of any law,   regulation,   holding or rule of

construction   providing that   ambiguities in an agreement or other document will

be construed against the party drafting such agreement or document.

 

      8.   DISPUTE   RESOLUTION.   In the event of any   dispute   arising   out of or

relating to this Note,   such dispute shall be resolved solely and exclusively by

confidential   binding arbitration with the Orange County branch of JAMS ("JAMS")

to be governed by JAMS' Commercial Rules of Arbitration in effect at the time of

the   commencement   of the   arbitration   (the "JAMS   RULES") and heard before one

arbitrator.   The parties shall attempt to mutually select the arbitrator. In the

event they are unable to mutually agree, the arbitrator shall be selected by the

procedures   prescribed   by the   JAMS   Rules.   Each   party   shall   bear   its   own

attorneys' fees,   expert witness fees, and costs incurred in connection with any

arbitration.

 

      IN WITNESS WHEREOF, the Company has executed and delivered this Note as of

the day and year and at the place first above written.

 

                                        INTEGRATED HEALTHCARE HOLDINGS, INC.

 

                                       By:

                                          --------------------------------------

                                              Larry B. Anderson, President

 

 

                                        2

<PAGE>

 

                                   EXHIBIT B-1

 

                                     FORM OF

                             STOCK PURCHASE WARRANT

 

60,000,000 Shares                                                January 27, 2005

 

      This certifies that, for good and valuable consideration, receipt of which

is hereby   acknowledged,   Kali P. Chaudhuri,   M.D. (the "HOLDER") is entitled to

purchase,   subject to the terms and conditions of this Warrant,   from Integrated

Healthcare   Holdings,   Inc, a Nevada corporation (the "COMPANY"),   Sixty Million

(60,000,000)   shares of the Company's   common stock (the "SHARES") in accordance

with Section 3 during the period   commencing   on the second   anniversary   of the

date hereof (the "COMMENCEMENT   DATE") and ending at 5:00 p.m.   California time,

on the date which is three and   one-half (3 1/2) years from the date hereof (the

"EXPIRATION   DATE"),   at which time this   Warrant   will   expire and become   void

unless earlier   terminated as provided   herein.   Notwithstanding   the foregoing,

this Warrant may not be exercised in an amount that would exceed,   when added to

the number of shares of common stock of the Company   previously   acquired by the

Holder by virtue of   exercise   of this   Warrant   (or any   replacement   Warrant),

twenty percent (20%) of the total number of outstanding   shares of capital stock

of the Company on a   Fully-Diluted   basis on the date of   exercise.   Capitalized

terms used herein without   definition have the meanings   ascribed to them in the

Rescission,   Restructuring and Assignment Agreement of even date herewith by and

among the Company, the Holder and certain other parties thereto.

 

      1. VESTING AND EXERCISE PRICE.

 

            (a) The right to   exercise   this   Warrant   shall   fully   vest on the

      Commencement Date.

 

            (b) The exercise or purchase price for the first   34,538,153   Shares

      purchased upon exercise of this Warrant shall be $0.003125 per Share,   and

      the   exercise or purchase   price for the   remainder of the Shares shall be

      $0.078 per Share if exercised   between January 27, 2007 and July 26, 2007,

      $0.11 per Share if   exercised   between July 27, 2007 and January 26, 2008,

      and $0.15   thereafter,   all subject to adjustment as provided in Section 2

      (the "EXERCISE PRICE").

 

      2. ANTI-DILUTION PROVISIONS.   The Exercise Price in effect at any time and

the number of Shares   purchasable   upon the   exercise   of this   Option   shall be

subject   to   adjustment   from   time to time   upon   the   happening   of any of the

following events:

 

            (a) If at any time the Company   subdivides its outstanding shares of

      Common Stock into a greater number of shares, the Exercise Price in effect

      immediately prior to such subdivision shall be proportionately reduced. If

      at any time the   outstanding   shares of Common   Stock of the   Company   are

      combined   into a smaller   number of shares,   the Exercise   Price in effect

      immediately prior to such combination shall be proportionately increased.

 

 

                                       1

<PAGE>

 

            (b)   Whenever   the   Exercise   Price   payable   upon   exercise of this

      Warrant   is   adjusted   pursuant   to this   Section   2, the number of Shares

      purchasable   upon   exercise   hereof   simultaneously   shall be   adjusted by

      multiplying   the   number   of   Shares   issuable   immediately   prior to such

      adjustment   by the   Exercise   Price in   effect   immediately   prior to such

      adjustment and dividing the product so obtained by the Exercise   Price, as

      adjusted.

 

            (c) the   Company   shall   give   notice to the   Holder of any event or

      transaction   that results in an adjustment in the Exercise   Price,   within

       ten (10) business days thereof,   at the Holder's   address as it appears on

      the books of the Company,   including a computation of such   adjustment and

      any   adjustment   in the number of Shares for which the Holder may exercise

      this Warrant and any further   information as shall be necessary to confirm

      the computation of such adjustments.

 

            (d) So long as this Warrant is outstanding,   if (i) the Company pays

      any dividend or makes any   distribution   upon the Common   Stock,   (ii) the

      Company   offers to the   holders of the Common   Stock for   subscription   or

      purchase   by them any   share of any   class of   capital   stock or any other

      rights    or    (iii)    any    capital    reorganization    of    the    Company,

      reclassification   of the   capital   stock   of the   Company,   consolidation,

      merger or other   business   combination of the Company with or into another

      entity,   sale, lease or transfer of all or substantially all of the assets

      of the Company to another entity, or voluntary or involuntary dissolution,

      liquidation   or winding up of the Company   shall be effected,   then in any

      such case,   the Company shall cause to be mailed by certified   mail to the

      Holder,   at least ten (10) days prior to the date   specified in clause (x)

      or (y) below, as the case may be, a notice   containing a brief description

      of the   proposed   action and   stating   the date on which (x) a record date

      shall be   established   for the purpose of such dividend,   distribution   or

      rights    offering    or    (y)    such    reclassification,     reorganization,

      consolidation,   merger,   conveyance,   sale, lease, transfer,   dissolution,

      liquidation   or winding   up shall   take   place and the date,   if any to be

      fixed, as of which the holders of Common Stock or other   securities   shall

      receive cash or other   property   deliverable   upon such   reclassification,

      reorganization,     consolidation,     merger,    conveyance,     dissolution,

      liquidation or winding up.

 

      3. EXERCISE AND PAYMENT.

 

            3.1 CASH EXERCISE.   At any time after the   Commencement   Date,   this

Warrant may be exercised,   in whole or in part, from time to time by the Holder,

during the term hereof,   by surrender of this Warrant and the Notice of Exercise

annexed   hereto duly   completed and executed by the Holder to the Company at the

principal executive offices of the Company,   together with payment in the amount

of the Exercise   Price then in effect,   as designated in the Notice of Exercise.

Payment may be in cash or by check payable to the order of the Company.

 

            3.2 NET ISSUANCE. In lieu of payment of the Exercise Price described

in Section   3.1,   the Holder may elect to   receive,   without   the payment by the

Holder   of any   additional   consideration,   Shares   equal   to the   value of this

Warrant or any portion   hereof by the   surrender of this Warrant or such portion

to the Company,   with the net issue   election   notice   annexed   hereto (the "NET

ISSUANCE   ELECTION   NOTICE")   duly   executed,   at the   office   of   the   Company.

Thereupon,   the Company   shall issue to the Holder such number of fully paid and

nonassessable Shares as is computed using the following formula:

 

 

                                        2

<PAGE>

 

where: X = Y (A-B)

           -------

              A

 

       X =     the   number of Shares to be issued to the Holder   pursuant   to

              this Section 3.

 

       Y =     the   number of Shares   covered   by this   Warrant in respect of

              which   the net   issuance   election   is made   pursuant   to this

              Section 3.

 

       A =     the   fair   market   value   of   one   Share,    as   determined   in

              accordance with the provisions of this Section 3.

 

       B =     the   Exercise   Price in effect   under this Warrant at the time

              the net issuance election is made pursuant to this Section 3.

 

For purposes of this Section 3, the "fair market value" per Share shall mean:

 

                    i. If the class of Shares is traded on a national securities

              exchange or is listed on the Nasdaq   National   Market (the "NNM")

              or other over-the-counter quotation system, the fair market value

              shall be the last reported sale price of a Share on such exchange

              or on the NNM or other   over-the-counter   quotation system on the

              last   business day before the   effective   date of exercise of the

              net issuance election or if no such sale is made on such day, the

              mean of the   closing   bid and asked   prices   for such day on such

              exchange, the NNM or over-the-counter quotation system; and

 

                   ii. If the class of Shares is not so listed   and bid and ask

              prices are not reported, the fair market value shall be the price

              per Share which the Company could obtain from a willing buyer for

              Shares sold by the Company,   as such price shall be determined in

              good faith by the Company's Board of Directors.

 

            3.3 NO PARTIAL   EXERCISE.   This Warrant,   if exercised,   may only be

exercised   as to the full number of Shares that may be permitted to be purchased

at the time of exercise. No partial exercises are permitted.

 

      4. DELIVERY OF CERTIFICATES. Within five (5) business days after exercise,

in whole or in part, of this Warrant, the Company shall issue in the name of and

deliver to the Holder,   a certificate   or   certificates   for the number of fully

paid and   nonassessable   Shares   which the Holder   shall have   requested   in the

Notice of Exercise or Net Issuance Election Notice. If this Warrant is exercised

in   part,   the   Company   shall   deliver   to the   Holder   a new   Warrant   for the

unexercised   portion of this Warrant at the time of delivery of such certificate

or certificates.

 

      5. NO   FRACTIONAL   SHARES.   No   fractional   Shares   or scrip   representing

fractional   Shares will be issued upon   exercise   of this   Warrant.   If upon any

exercise of this Warrant a fraction of a Share results, the Company will pay the

Holder the   difference   between the cash value of the   fractional   Share and the

portion of the Exercise Price allocable to the fractional Share.

 

 

                                        3

<PAGE>

 

      6. CHARGES, TAXES AND EXPENSES. The Holder shall pay all transfer taxes or

other incidental   charges, if any, in connection with the transfer of the Shares

purchased pursuant to the exercise hereof from the Company to the Holder.

 

      7. LOSS, THEFT,   DESTRUCTION OR MUTILATION OF WARRANT. Upon receipt by the

Company   of   evidence   reasonably    satisfactory   to   it   of   the   loss,   theft,

destruction   or   mutilation   of this   Warrant,   and in case of   loss,   theft   or

destruction,   of indemnity or security   reasonably   satisfactory to the Company,

and upon   reimbursement   to the Company of all   reasonable   expenses   incidental

thereto, and upon surrender and cancellation of this Warrant, if mutilated,   the

Company   will make and   deliver a new Warrant of like tenor and dated as of such

cancellation, in lieu of this Warrant.

 

      8. RIGHTS AS   SHAREHOLDER.   Prior to exercise of this Warrant,   the Holder

shall not be entitled to any rights as a shareholder of the Company with respect

to the Shares,   including   (without   limitation)   the right to vote such Shares,

receive dividends or other distributions   thereon, or be notified of Shareholder

meetings,   and   the   Holder   shall   not be   entitled   to   any   notice   or   other

communication concerning the business or affairs of the Company. However, in the

event of any taking by the   Company   of a record of the   holders of any class of

securities for the purpose of determining   the holders   thereof who are entitled

to receive any dividend (other than a cash dividend) or other distribution,   any

right to subscribe   for,   purchase or otherwise   acquire any Common Stock or any

other   securities or property,   or to receive any other right, the Company shall

mail to each   Holder of this   Warrant,   at least ten (10) days prior to the date

specified   therein,   a notice specifying the date on which any such record is to

be taken for the purpose of such dividend, distribution or right, and the amount

and character of such dividend, distribution or right.

 

      9. RESTRICTED SECURITIES. The Holder understands that this Warrant and the

Shares   purchasable   hereunder   constitute   "restricted   securities"   under   the

federal   securities   laws   inasmuch as they are, or will be,   acquired   from the

Company in transactions not involving a public offering and accordingly may not,

under such laws and applicable   regulations,   be resold or   transferred   without

registration   under the Securities Act of 1933 (the "1933 ACT") or an applicable

exemption from such registration.   In this connection,   the Holder   acknowledges

that Rule 144 of the Securities and Exchange   Commission (the "SEC") is not now,

and may not in the future be, available for resale of the Warrant and the Shares

purchasable hereunder. Unless the Shares are subsequently registered, the Holder

further   acknowledges   that the securities   legend on Exhibit A to the Notice of

Exercise attached hereto shall be placed on any Shares issued to the Holder upon

exercise of this Warrant.

 

       10.   CERTIFICATION OF INVESTMENT   PURPOSE.   Unless a current   registration

statement   under the 1933 Act is in effect with respect to the   securities to be

issued upon exercise of this Warrant,   the Holder   covenants and agrees that, at

the   time   of   exercise   hereof,   he   will   deliver   to the   Company   a   written

certification executed by the Holder that the securities acquired by such Holder

upon   exercise   hereof are for the   account   of such   Holder   and   acquired   for

investment   purposes only and that such   securities are not acquired with a view

to, or for sale in connection with, any distribution thereof.

 

 

                                       4

<PAGE>

 

      11.   TRANSFERABILITY.   This Warrant   shall be   transferable   by the Holder

subject to compliance with law.

 

      12. MISCELLANEOUS.

 

            12.1 CONSTRUCTION.   Unless the context indicates otherwise, the term

"Holder" shall include any   transferee or   transferees of this Warrant,   and the

term "Warrant" shall include any and all warrants   outstanding   pursuant to this

Agreement,   including those   evidenced by a certificate or   certificates   issued

upon division, exchange, substitution or transfer.

 

            12.2 RESTRICTIONS.   By receipt of this Warrant, the Holder makes the

same   representations   with   respect to the   acquisition   of this Warrant as the

Holder is required to make upon the exercise of this Warrant and   acquisition of

the Shares   purchasable   hereunder as set forth in the Form of Investment Letter

attached as Exhibit A to the Notice of Exercise attached hereto.

 

            12.3 NOTICES.   Unless   otherwise   provided,   any notice   required or

permitted   under   this   Warrant   shall be given in   writing   and shall be deemed

effectively   given upon   personal   delivery to the party to be notified or three

(3) days following   deposit with the United States Post Office, by registered or

certified   mail,   postage   prepaid and addressed to the party to be notified (or

one (1) day following   timely   deposit with a reputable   overnight   courier with

next day delivery   instructions),   or upon confirmation of receipt by the sender

of any notice by facsimile   transmission,   at the address   indicated below or at

such other address as such party may designate by ten (10) days' advance written

notice to the other parties.

 

     If to the Company, addressed to:      Integrated Healthcare Holdings, Inc.

                                          695 Town Center Drive, Suite 260

                                          Costa Mesa, CA 92626

                                          Attention: Chief Executive Officer

 

     If to the Holder, addressed to:       c/o Strategic Global Management, Inc.

                                          6800 Indiana Avenue, Suite 130

                                           Riverside, CA 92506

                                          Attention: William E. Thomas, Esq.

 

            12.4   GOVERNING LAW. This Warrant shall be governed by and construed

under   the laws of the   State of   California   as   applied   to   agreements   among

California    residents   entered   into   and   to   be   performed    entirely   within

California.

 

            12.5 ENTIRE   AGREEMENT.   This   Warrant,   the exhibits and   schedules

hereto,   and the documents   referred to herein,   constitute the entire agreement

and   understanding   of the   parties   hereto with   respect to the subject   matter

hereof,    and    supersede    all   prior   and    contemporaneous    agreements    and

understandings, whether oral or written, between the parties hereto with respect

to the subject matter hereof.

 

 

                                       5

<PAGE>

 

            12.6   BINDING   EFFECT.   This   Warrant   and the   various   rights   and

obligations   arising hereunder shall inure to the benefit of and be binding upon

the Company and its   successors   and assigns,   and Holder and its successors and

assigns.

 

            12.7   WAIVER;   CONSENT.   This   Warrant may not be changed,   amended,

terminated,   augmented,   rescinded or discharged (other than by performance), in

whole or in part,   except by a writing   executed by the parties   hereto,   and no

waiver of any of the   provisions   or   conditions   of this   Warrant or any of the

rights of a party hereto shall be effective or binding   unless such waiver shall

be in   writing   and   signed   by the party   claimed   to have   given or   consented

thereto.

 

            12.8   SEVERABILITY.   If one or more   provisions   of this Warrant are

held to be unenforceable   under applicable law, such provision shall be excluded

from this Warrant and the balance of the Warrant shall be interpreted as if such

provision   were so excluded and the balance shall be   enforceable   in accordance

with its terms.

 

            12.9 DISPUTE RESOLUTION.   In the event of any dispute arising out of

or   relating   to this   Warrant,   such   dispute   shall   be   resolved   solely   and

exclusively by confidential binding arbitration with the Orange County branch of

JAMS ("JAMS") to be governed by JAMS'   Commercial Rules of Arbitration in effect

at the time of the   commencement of the arbitration (the "JAMS RULES") and heard

before   one   arbitrator.   The   parties   shall   attempt   to   mutually   select the

arbitrator. In the event they are unable to mutually agree, the arbitrator shall

be selected by the   procedures   prescribed   by the JAMS Rules.   Each party shall

bear its own   attorneys'   fees,   expert   witness   fees,   and costs   incurred   in

connection with any arbitration.

 

      IN WITNESS WHEREOF,   the parties have executed this Warrant as of the date

first above written.

 

 

"HOLDER":                               -----------------------------------------

                                       KALI P. CHAUDHURI, M.D., an individual

 

 

 

"COMPANY":                              INTEGRATED HEALTHCARE HOLDINGS,

                                        INC., a Nevada corporation

 

 

                                       By:

                                          --------------------------------------

                                             Larry B. Anderson, President

 

 

                                        6

<PAGE>

 

                               NOTICE OF EXERCISE

 

To: INTEGRATED HEALTHCARE HOLDINGS, INC.

 

            The undersigned   hereby elects to purchase   _____________   shares of

_________ Stock (the "Shares") of Integrated Healthcare Holdings, Inc., a Nevada

corporation (the "Company")   pursuant to the terms of the attached Warrant,   and

tenders   herewith   payment of the   purchase   price   pursuant to the terms of the

Warrant.

 

            Attached   as   Exhibit   A   is   an   investment   representation   letter

addressed to the Company and executed by the   undersigned as required by Section

10 of the Warrant.

 

            Please issue   certificates   representing   the Common Stock purchased

hereunder in the names and in the denominations   indicated on Exhibit A attached

hereto.

 

            Please   issue a new   Warrant   for   the   unexercised   portion   of the

attached Warrant, if any, in the name of the undersigned.

 

Dated:

       --------------------------------       -----------------------------------

                                             Name:

                                                   -----------------------------

 

                                             Title:

                                                    -----------------------------

 

<PAGE>

 

                          NET ISSUANCE ELECTION NOTICE

 

To: INTEGRATED HEALTHCARE HOLDINGS, INC.

Date:_____________

 

      The undersigned hereby elects under Section 3.2 of the attached Warrant to

surrender the right to purchase   ___________   shares of   ___________   Stock (the

"Shares")   pursuant to the attached Warrant.   The   Certificate(s) for the Shares

issuable   upon   such net   issuance   election   shall be issued in the name of the

undersigned or as otherwise indicated below.

 

      Attached as Exhibit A is an investment   representation letter addressed to

the Company and   executed   by the   undersigned   as required by Section 10 of the

Warrant.

 

      Please issue certificates   representing the Shares purchased   hereunder in

the names and in the denominations indicated on Exhibit A attached hereto.

 

      Please   issue a new Warrant for the   unexercised   portion of the   attached

Warrant, if any, in the name of the undersigned.

 

 

---------------------------

Signature

 

 

---------------------------

Name for Registration

 

 

---------------------------

Mailing Address

 

<PAGE>

 

                                    EXHIBIT A

 

To: INTEGRATED HEALTHCARE HOLDINGS, INC.

 

      In connection with the purchase by the undersigned of _________   shares of

Common Stock (the "SHARES") of Integrated   Healthcare   Holdings,   Inc., a Nevada

corporation (the   "COMPANY"),   upon exercise of that certain Warrant dated as of

January 27, 2005, the undersigned hereby represents and warrants as follows:

 

      The Shares to be received by the undersigned   upon exercise of the Warrant

are being acquired for his own account,   not as a nominee or agent, and not with

a view to resale or distribution of any part thereof, and the undersigned has no

present   intention   of selling,   granting   any   participation   in, or   otherwise

distributing the same. The undersigned   further represents that he does not have

any contract,   undertaking,   agreement or   arrangement   with any person to sell,

transfer   or grant   participation   to such person or to any third   person,   with

respect   to the   Shares.   The   undersigned   believes   he has   received   all   the

information   he considers   necessary   or   appropriate   for   deciding   whether to

purchase the Shares.

 

      The   undersigned    understands   that   the   Shares   are    characterized   as

"restricted   securities" under the federal   securities laws inasmuch as they are

being acquired from the Company in transactions   not involving a public offering

and that under   such laws and   applicable   regulations   such   securities   may be

resold   without   registration   under the Securities Act of 1933, as amended (the

"ACT"),   only   in   certain   limited   circumstances.    In   this   connection,   the

undersigned   represents   that he is familiar   with SEC Rule 144, as presently in

effect, and understands the resale limitations imposed thereby and by the Act.

 

      Without in any way   limiting   the   representations   set forth   above,   the

undersigned   agrees   not to make any   disposition   of all or any   portion of the

Shares unless and until:

 

      There is then in effect a   registration   statement   under the Act covering

such proposed   disposition and such   disposition is made in accordance with such

registration statement; or

 

             (i)   The   undersigned   has   notified   the   Company   of the   proposed

      disposition and shall have furnished the Company with a detailed statement

      of the circumstances surrounding the proposed disposition, and

 

            (ii) if requested, the undersigned has furnished the Company with an

      opinion of   counsel,   reasonably   satisfactory   to the   Company   that such

      disposition   will not require   registration   of such shares under the Act.

      The Company will not require an opinion of counsel for sales made pursuant

      to Rule 144 except in unusual circumstances.

 

      The undersigned understands the instruments evidencing the Shares may bear

a legend similar to the following:

 

<PAGE>

 

      THE SECURITIES   REPRESENTED BY THIS   CERTIFICATE   HAVE NOT BEEN REGISTERED

UNDER THE   SECURITIES   ACT OF 1933;   THEY HAVE BEEN   ACQUIRED   BY THE HOLDER FOR

INVESTMENT AND MAY NOT BE PLEDGED, HYPOTHECATED,   SOLD, TRANSFERRED OR OTHERWISE

DISPOSED OF EXCEPT AS MAY BE AUTHORIZED   UNDER THE   SECURITIES   ACT OF 1933, AND

THE RULES AND REGULATIONS PROMULGATED THEREUNDER.

 

Dated:

       --------------------------------      ------------------------------------

 

                                            Name:

                                                    -----------------------------

 

                                            Title:

                                                   -----------------------------

 

<PAGE>

 

                                   EXHIBIT B-2

 

                                      FORM OF

                             STOCK PURCHASE WARRANT

 

14,700,000 Shares                                                January 27, 2005

 

      This certifies that, for good and valuable consideration, receipt of which

is hereby   acknowledged,   William   E.   Thomas   (the   "HOLDER")   is   entitled   to

purchase,   subject to the terms and conditions of this Warrant,   from Integrated

Healthcare   Holdings,   Inc,   a   Nevada   corporation   (the   "COMPANY"),   Fourteen

Million,   Seven Hundred   Thousand   (14,700,000)   shares of the Company's   common

stock (the "SHARES") in accordance   with Section 3 during the period   commencing

on the second   anniversary   of the date   hereof   (the   "COMMENCEMENT   DATE") and

ending at 5:00 p.m.   California time, on the date which is three and one-half (3

1/2) years from the date   hereof   (the   "EXPIRATION   DATE"),   at which time this

Warrant   will   expire and become   void   unless   earlier   terminated   as provided

herein.   Notwithstanding the foregoing,   this Warrant may not be exercised in an

amount that would exceed,   when added to the number of shares of common stock of

the   Company   previously   acquired   by the Holder by virtue of   exercise of this

Warrant (or any replacement Warrant), four and nine-tenths percent (4.9%) of the

total   number   of   outstanding   shares   of   capital   stock of the   Company   on a

Fully-Diluted   basis on the date of   exercise.   Capitalized   terms   used   herein

without   definition   have   the   meanings   ascribed   to them   in the   Rescission,

Restructuring   and   Assignment   Agreement of even date herewith by and among the

Company, the Holder and certain other parties thereto.

 

      1. VESTING AND EXERCISE PRICE.

 

            (a) The right to   exercise   this   Warrant   shall   fully   vest on the

      Commencement Date.

 

            (b) The exercise or purchase   price for the first   8,461,847   Shares

      purchased upon exercise of this Warrant shall be $0.003125 per Share,   and

      the   exercise or purchase   price for the   remainder of the Shares shall be

      $0.078 per Share if exercised   between January 27, 2007 and July 26, 2007,

      $0.11 per Share if   exercised   between July 27, 2007 and January 26, 2008,

      and $0.15   thereafter,   all subject to adjustment as provided in Section 2

      (the "EXERCISE PRICE").

 

      2. ANTI-DILUTION PROVISIONS.   The Exercise Price in effect at any time and

the number of Shares   purchasable   upon the   exercise   of this   Option   shall be

subject   to   adjustment   from   time to time   upon   the   happening   of any of the

following events:

 

            (a) If at any time the Company   subdivides its outstanding shares of

      Common Stock into a greater number of shares, the Exercise Price in effect

      immediately prior to such subdivision shall be proportionately reduced. If

      at any time the   outstanding   shares of Common   Stock of the   Company   are

      combined   into a smaller   number of shares,   the Exercise   Price in effect

      immediately prior to such combination shall be proportionately increased.

 

 

                                       1

<PAGE>

 

            (b)   Whenever   the   Exercise   Price   payable   upon   exercise of this

      Warrant   is   adjusted   pursuant   to this   Section   2, the number of Shares

      purchasable   upon   exercise   hereof   simultaneously   shall be   adjusted by

      multiplying   the   number   of   Shares   issuable   immediately   prior to such

      adjustment   by the   Exercise   Price in   effect   immediately   prior to such

      adjustment and dividing the product so obtained by the Exercise   Price, as

      adjusted.

 

            (c) the   Company   shall   give   notice to the   Holder of any event or

      transaction   that results in an adjustment in the Exercise   Price,   within

      ten (10) business days thereof,   at the Holder's   address as it appears on

      the books of the Company,   including a computation of such   adjustment and

      any   adjustment   in the number of Shares for which the Holder may exercise

      this Warrant and any further   information as shall be necessary to confirm

      the computation of such adjustments.

 

            (d) So long as this Warrant is outstanding,   if (i) the Company pays

      any dividend or makes any   distribution   upon the Common   Stock,   (ii) the

      Company   offers to the   holders of the Common   Stock for   subscription   or

      purchase   by them any   share of any   class of   capital   stock or any other

      rights    or    (iii)    any    capital    reorganization    of    the    Company,

      reclassification   of the   capital   stock   of the   Company,   consolidation,

      merger or other   business   combination of the Company with or into another

      entity,   sale, lease or transfer of all or substantially all of the assets

      of the Company to another entity, or voluntary or involuntary dissolution,

      liquidation   or winding up of the Company   shall be effected,   then in any

      such case,   the Company shall cause to be mailed by certified   mail to the

      Holder,   at least ten (10) days prior to the date   specified in clause (x)

      or (y) below, as the case may be, a notice   containing a brief description

      of the   proposed   action and   stating   the date on which (x) a record date

      shall be   established   for the purpose of such dividend,   distribution   or

       rights    offering    or    (y)    such    reclassification,     reorganization,

      consolidation,   merger,   conveyance,   sale, lease, transfer,   dissolution,

      liquidation   or winding   up shall   take   place and the date,   if any to be

      fixed, as of which the holders of Common Stock or other   securities   shall

      receive cash or other   property   deliverable   upon such   reclassification,

      reorganization,     consolidation,     merger,    conveyance,     dissolution,

      liquidation or winding up.

 

      3. EXERCISE AND PAYMENT.

 

            3.1 CASH EXERCISE.   At any time after the   Commencement   Date,   this

Warrant may be exercised,   in whole or in part, from time to time by the Holder,

during the term hereof,   by surrender of this Warrant and the Notice of Exercise

annexed   hereto duly   completed and executed by the Holder to the Company at the

principal executive offices of the Company,   together with payment in the amount

of the Exercise   Price then in effect,   as designated in the Notice of Exercise.

Payment may be in cash or by check payable to the order of the Company.

 

            3.2 NET ISSUANCE. In lieu of payment of the Exercise Price described

in Section   3.1,   the Holder may elect to   receive,   without   the payment by the

Holder   of any   additional   consideration,   Shares   equal   to the   value of this

Warrant or any portion   hereof by the   surrender of this Warrant or such portion

to the Company,   with the net issue   election   notice   annexed   hereto (the "NET

ISSUANCE   ELECTION   NOTICE")   duly   executed,   at the   office   of   the   Company.

Thereupon,   the Company   shall issue to the Holder such number of fully paid and

nonassessable Shares as is computed using the following formula:

 

 

                                       2

<PAGE>

 

where: X = Y (A-B)

           -------

              A

 

       X =     the   number of Shares to be issued to the Holder   pursuant   to

              this Section 3.

 

       Y =     the   number of Shares   covered   by this   Warrant in respect of

              which   the net   issuance   election   is made   pursuant   to this

              Section 3.

 

       A =     the   fair   market   value   of   one   Share,    as   determined   in

              accordance with the provisions of this Section 3.

 

       B =     the   Exercise   Price in effect   under this Warrant at the time

              the net issuance election is made pursuant to this Section 3.

 

For purposes of this Section 3, the "fair market value" per Share shall mean:

 

                   i. If the class of Shares is traded on a national securities

              exchange or is listed on the Nasdaq   National   Market (the "NNM")

              or other over-the-counter quotation system, the fair market value

              shall be the last reported sale price of a Share on such exchange

              or on the NNM or other   over-the-counter   quotation system on the

              last   business day before the   effective   date of exercise of the

              net issuance election or if no such sale is made on such day, the

               mean of the   closing   bid and asked   prices   for such day on such

              exchange, the NNM or over-the-counter quotation system; and

 

                   ii. If the class of Shares is not so listed   and bid and ask

              prices are not reported, the fair market value shall be the price

              per Share which the Company could obtain from a willing buyer for

              Shares sold by the Company,   as such price shall be determined in

              good faith by the Company's Board of Directors.

 

            3.3 NO PARTIAL   EXERCISE.   This Warrant,   if exercised,   may only be

exercised   as to the full number of Shares that may be permitted to be purchased

at the time of exercise. No partial exercises are permitted.

 

      4. DELIVERY OF CERTIFICATES. Within five (5) business days after exercise,

in whole or in part, of this Warrant, the Company shall issue in the name of and

deliver to the Holder,   a certificate   or   certificates   for the number of fully

paid and   nonassessable   Shares   which the Holder   shall have   requested   in the

Notice of Exercise or Net Issuance Election Notice. If this Warrant is exercised

in   part,   the   Company   shall   deliver   to the   Holder   a new   Warrant   for the

unexercised   portion of this Warrant at the time of delivery of such certificate

or certificates.

 

      5. NO   FRACTIONAL   SHARES.   No   fractional   Shares   or scrip   representing

fractional   Shares will be issued upon   exercise   of this   Warrant.   If upon any

exercise of this Warrant a fraction of a Share results, the Company will pay the

Holder the   difference   between the cash value of the   fractional   Share and the

portion of the Exercise Price allocable to the fractional Share.

 

 

                                       3

<PAGE>

 

      6. CHARGES, TAXES AND EXPENSES. The Holder shall pay all transfer taxes or

other incidental   charges, if any, in connection with the transfer of the Shares

purchased pursuant to the exercise hereof from the Company to the Holder.

 

      7. LOSS, THEFT,   DESTRUCTION OR MUTILATION OF WARRANT. Upon receipt by the

Company   of   evidence   reasonably    satisfactory   to   it   of   the   loss,   theft,

destruction   or   mutilation   of this   Warrant,   and in case of   loss,   theft   or

destruction,   of indemnity or security   reasonably   satisfactory to the Company,

and upon   reimbursement   to the Company of all   reasonable   expenses   incidental

thereto, and upon surrender and cancellation of this Warrant, if mutilated,   the

Company   will make and   deliver a new Warrant of like tenor and dated as of such

cancellation, in lieu of this Warrant.

 

      8. RIGHTS AS   SHAREHOLDER.   Prior to exercise of this Warrant,   the Holder

shall not be entitled to any rights as a shareholder of the Company with respect

to the Shares,   including   (without   limitation)   the right to vote such Shares,

receive dividends or other distributions   thereon, or be notified of Shareholder

meetings,   and   the   Holder   shall   not be   entitled   to   any   notice   or   other

communication concerning the business or affairs of the Company. However, in the

event of any taking by the   Company   of a record of the   holders of any class of

securities for the purpose of determining   the holders   thereof who are entitled

to receive any dividend (other than a cash dividend) or other distribution,   any

right to subscribe   for,   purchase or otherwise   acquire any Common Stock or any

other   securities or property,   or to receive any other right, the Company shall

mail to each   Holder of this   Warrant,   at least ten (10) days prior to the date

specified   therein,   a notice specifying the date on which any such record is to

be taken for the purpose of such dividend, distribution or right, and the amount

and character of such dividend, distribution or right.

 

      9. RESTRICTED SECURITIES. The Holder understands that this Warrant and the

Shares   purchasable   hereunder   constitute   "restricted   securities"   under   the

federal   securities   laws   inasmuch as they are, or will be,   acquired   from the

Company in transactions not involving a public offering and accordingly may not,

under such laws and applicable   regulations,   be resold or   transferred   without

registration   under the Securities Act of 1933 (the "1933 ACT") or an applicable

exemption from such registration.   In this connection,   the Holder   acknowledges

that Rule 144 of the Securities and Exchange   Commission (the "SEC") is not now,

and may not in the future be, available for resale of the Warrant and the Shares

purchasable hereunder. Unless the Shares are subsequently registered, the Holder

further   acknowledges   that the securities   legend on Exhibit A to the Notice of

Exercise attached hereto shall be placed on any Shares issued to the Holder upon

exercise of this Warrant.

 

      10.   CERTIFICATION OF INVESTMENT   PURPOSE.   Unless a current   registration

statement   under the 1933 Act is in effect with respect to the   securities to be

issued upon exercise of this Warrant,   the Holder   covenants and agrees that, at

the   time   of   exercise   hereof,   he   will   deliver   to the   Company   a   written

certification executed by the Holder that the securities acquired by such Holder

upon   exercise   hereof are for the   account   of such   Holder   and   acquired   for

investment   purposes only and that such   securities are not acquired with a view

to, or for sale in connection with, any distribution thereof.

 

 

                                       4

<PAGE>

 

      11.   TRANSFERABILITY.   This Warrant   shall be   transferable   by the Holder

subject to compliance with law.

 

      12. MISCELLANEOUS.

 

            12.1 CONSTRUCTION.   Unless the context indicates otherwise, the term

"Holder" shall include any   transferee or   transferees of this Warrant,   and the

term "Warrant" shall include any and all warrants   outstanding   pursuant to this

Agreement,   including those   evidenced by a certificate or   certificates   issued

upon division, exchange, substitution or transfer.

 

            12.2 RESTRICTIONS.   By receipt of this Warrant, the Holder makes the

same   representations   with   respect to the   acquisition   of this Warrant as the

Holder is required to make upon the exercise of this Warrant and   acquisition of

the Shares   purchasable   hereunder as set forth in the Form of Investment Letter

attached as Exhibit A to the Notice of Exercise attached hereto.

 

            12.3 NOTICES.   Unless   otherwise   provided,   any notice   required or

permitted   under   this   Warrant   shall be given in   writing   and shall be deemed

effectively   given upon   personal   delivery to the party to be notified or three

(3) days following   deposit with the United States Post Office, by registered or

certified   mail,   postage   prepaid and addressed to the party to be notified (or

one (1) day following   timely   deposit with a reputable   overnight   courier with

next day delivery   instructions),   or upon confirmation of receipt by the sender

of any notice by facsimile   transmission,   at the address   indicated below or at

such other address as such party may designate by ten (10) days' advance written

notice to the other parties.

 

      If to the Company, addressed to:      Integrated Healthcare Holdings, Inc.

                                          695 Town Center Drive, Suite 260

                                          Costa Mesa, CA 92626

                                          Attention: Chief Executive Officer

 

     If to the Holder, addressed to:       c/o Strategic Global Management, Inc.

                                          6800 Indiana Avenue, Suite 130

                                          Riverside, CA 92506

                                           Attention: William E. Thomas, Esq.

 

            12.4   GOVERNING LAW. This Warrant shall be governed by and construed

under   the laws of the   State of   California   as   applied   to   agreements   among

California    residents   entered   into   and   to   be   performed    entirely   within

California.

 

            12.5 ENTIRE   AGREEMENT.   This   Warrant,   the exhibits and   schedules

hereto,   and the documents   referred to herein,   constitute the entire agreement

and   understanding   of the   parties   hereto with   respect to the subject   matter

hereof,    and    supersede    all   prior   and    contemporaneous    agreements    and

understandings, whether oral or written, between the parties hereto with respect

to the subject matter hereof.

 

 

                                        5

<PAGE>

 

            12.6   BINDING   EFFECT.   This   Warrant   and the   various   rights   and

obligations   arising hereunder shall inure to the benefit of and be binding upon

the Company and its   successors   and assigns,   and Holder and its successors and

assigns.

 

            12.7   WAIVER;   CONSENT.   This   Warrant may not be changed,   amended,

terminated,   augmented,   rescinded or discharged (other than by performance), in

whole or in part,   except by a writing   executed by the parties   hereto,   and no

waiver of any of the   provisions   or   conditions   of this   Warrant or any of the

rights of a party hereto shall be effective or binding   unless such waiver shall

be in   writing   and   signed   by the party   claimed   to have   given or   consented

thereto.

 

            12.8   SEVERABILITY.   If one or more   provisions   of this Warrant are

held to be unenforceable   under applicable law, such provision shall be excluded

from this Warrant and the balance of the Warrant shall be interpreted as if such

provision   were so excluded and the balance shall be   enforceable   in accordance

with its terms.

 

            12.9 DISPUTE RESOLUTION.   In the event of any dispute arising out of

or   relating   to this   Warrant,   such   dispute   shall   be   resolved   solely   and

exclusively by confidential binding arbitration with the Orange County branch of

JAMS ("JAMS") to be governed by JAMS'   Commercial Rules of Arbitration in effect

at the time of the   commencement of the arbitration (the "JAMS RULES") and heard

before   one   arbitrator.   The   parties   shall   attempt   to   mutually   select the

arbitrator. In the event they are unable to mutually agree, the arbitrator shall

be selected by the   procedures   prescribed   by the JAMS Rules.   Each party shall

bear its own   attorneys'   fees,   expert   witness   fees,   and costs   incurred   in

connection with any arbitration.

 

      IN WITNESS WHEREOF,   the parties have executed this Warrant as of the date

first above written.

 

 

"HOLDER":                               -----------------------------------------

                                       WILLIAM E. THOMAS, an individual

 

 

"COMPANY":                              INTEGRATED HEALTHCARE HOLDINGS, INC.,

                                       a Nevada corporation

 

 

                                        By:

                                          --------------------------------------

                                             Larry B. Anderson, President

 

 

                                       6

<PAGE>

 

                                NOTICE OF EXERCISE

 

To: INTEGRATED HEALTHCARE HOLDINGS, INC.

 

            The undersigned   hereby elects to purchase   _____________   shares of

_________ Stock (the "Shares") of Integrated Healthcare Holdings, Inc., a Nevada

corporation (the "Company")   pursuant to the terms of the attached Warrant,   and

tenders   herewith   payment of the   purchase   price   pursuant to the terms of the

Warrant.

 

            Attached   as   Exhibit   A   is   an   investment   represen


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more